In a report released today, Christopher Raymond from Piper Sandler maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), ...

In a report released today, Gena Wang from Barclays maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), with a price ...

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Incyte (INCY) and Vertex Pharmaceuticals (VRTX ... at its current share price levels.

The most recent trading session ended with Vertex Pharmaceuticals (VRTX) standing at $416.96 ... are directly correlated with near-term stock prices. To exploit this, we've formed the Zacks ...

Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INC (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our P/B Growth Investor model based on the published ...

In the latest market close, Vertex Pharmaceuticals (VRTX) reached $409.56, with a -0.62% movement compared to the previous day. This change was narrower than the S&P 500's 1.54% loss on the day.

Gas prices dropped again, to $3.43 per gallon for the average ... Inc. (GIS); ServiceNow Inc (NOW); Vertex Pharmaceuticals, Inc. (VRTX). CIEN, GIS, MDLZ, CRWD, NOW, MRK, VRTX, HPE May Stock Recovery ...

Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price objective cut by Wells Fargo & Company from $555.00 to $460.00 in a report issued on Friday,Benzinga reports. The brokerage ...

Following Trump’s victory, small-cap, value, and cyclical shares saw a spike in price; however ... Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), in the third quarter 2024 investor letter.

Many offers of remuneration would enhance patient quality of life, but that doesn't render them lawful," the HHS added. VRTX Price Action: Vertex stock is down 1.41% at $418.29 at publication ...